Skip Navigation
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
< Back

'dipeptidyl-peptidase iv inhibitors'
Run an advanced search on this term

Search within:  

Sort results by:      



Filter results by:

1-8 of 8  
 
1.  
Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes. 2013 Jul. NGC:009997
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
3.  
4.  
Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea. 2010 Aug. NGC:008155
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
5.  
VA/DoD clinical practice guideline for the management of diabetes mellitus. 1999 Dec (revised 2010 Aug). NGC:008116
Department of Defense - Federal Government Agency [U.S.]; Department of Veterans Affairs - Federal Government Agency [U.S.]; Veterans Health Administration - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
6.  
Management of diabetes. A national clinical guideline. 2001 Nov (revised 2010 Mar). NGC:007892
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
Diabetes management in the long term care setting. 2002 (revised 2010). NGC:009849
American Medical Directors Association - Professional Association. View all guidelines by the developer(s)
8.  
Type 2 diabetes. The management of type 2 diabetes. 2004 Jun 17 (revised 2009 May). NGC:007460
National Clinical Guideline Centre for Acute and Chronic Conditions - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-8 of 8